Vnitr Lek 2021, 67(2):92-96 | DOI: 10.36290/vnl.2021.020

Extraintestinal complications of inflammatory bowel diseases

Vít Navrátil1, Silvia Cveková1, Peter Slodička1, Květoslava Aiglová1, Barbora Pipek1,2,3, Přemysl Falt1
1 II. interní klinika - gastroenterologická a geriatrická LF UP a FN Olomouc
2 Centrum péče o zažívací trakt, Nemocnice AGEL Ostrava Vítkovice, a. s.
3 Ostravská univerzita, Lékařská fakulta, Ostrava

Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC). Those are chronic gastrointestinal disorders of inflammatory nature and not fully known etiology. As a result of their immune-mediated mechanism and complex impact on the whole organism other organs than gastrointestinal system may be affected in many ways. These extraintestinal manifestations (EIM) and complications may severely deteriorate prognosis of the patient, cause his morbidity and worsen the quality of life. While classical extraintestinal manifestations, such as enteropathic arthropathy, skin or eye involvement or primary sclerosing cholangitis, share common immunopathological mechanism with IBD, whole range of other disorders may result from various anatomical or metabolic abnormalities caused by IBD or its treatment. This review focus on the most common extraintestinal complications, such as anaemia, metabolic bone disease, biliary and urolithiasis, which we meet in our daily clinical practice.

Keywords: anemia, inflammatory bowel disease, lithiasis, metabolic bone disease, extraintestinal complications.

Published: April 21, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Navrátil V, Cveková S, Slodička P, Aiglová K, Pipek B, Falt P. Extraintestinal complications of inflammatory bowel diseases. Vnitr Lek. 2021;67(2):92-96. doi: 10.36290/vnl.2021.020.
Download citation

References

  1. Ferreira SDC, Oliveira BBMD, Morsoletto AM et al. Extraintestinal manifestations of inflammatory bowel disease: Clinical aspects and pathogenesis. J Gastroenterol Dig Dis 2018; 3(1): 4-11.
  2. Vavricka SR, Schoepfer A, Scharl M et al. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis 2015; 21(8): 1982-1992. Go to original source... Go to PubMed...
  3. Zbořil V a kol. Idiopatické střevní záněty. Praha: Mladá fronta, 2018.
  4. Hrdlička L, Kohout P, Liberda M et al. Doporučený postup pro diagnostiku a léčbu anémie u IBD. Gastroent Hepatol 2012; 66(4): 280-285.
  5. Harpavat M, Keljo DJ, Regueiro MD. Metabolic bone disease in inflammatory bowel disease. J Clin Gastroenterol. 2004 Mar; 38(3): 218-224. Go to original source... Go to PubMed...
  6. Fojtík P, Urban O, Falt P, Novosad P. Výživa a sekundární osteoporóza, Interní Med. 2009; 11(12): 561-568.
  7. Conly JM, Stein K, Worobetz L et al. The contribution of vitamin K2 (menaquinones), produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol 1994; 89: 915-923.
  8. Buchman, A. Metabolic Bone Disease and Inflammatory Bowel Disease, American Journal of Gastroenterology: June 2007 - Volume 102 - Issue - p 49-55. Go to original source...
  9. Ambruzs JM, Larsen CP. Renal Manifestations of Inflammatory Bowel Disease. Rheum Dis Clin North Am 2018; 44(4): 699-714. Go to original source... Go to PubMed...
  10. Teplan V, Honsová E, Lukáš M Renální onemocnění pacientů s idiopatickými střevními záněty. Gastroent Hepatol 2020; 74(3): 256-266. Go to original source...
  11. Corica D, Romano C. Renal Involvement in Inflammatory Bowel Diseases. J Crohns Colitis 2016; 10(2): 226-235. Go to original source... Go to PubMed...
  12. Katsanos K, Tsianos EV. The kidneys in inflammatory bowel disease. Ann Gastroenterol 2002; 15(1): 41-52.
  13. Maconi G, Bolzacchini E, Dell'Era A et al. Portal vein thrombosis in inflammatory bowel diseases: A single‑center case series, Journal of Crohn's and Colitis, 2012; 6(3): 362-367. Go to original source... Go to PubMed...
  14. Sinagra E, Aragona E, Romano C et. al. The Role of Portal Vein Thrombosis in the Clinical Course of Inflammatory Bowel Diseases: Report on Three Cases and Review of the Literature, Gastroenterology Research and Practice, 2012, 7 pages. Go to original source... Go to PubMed...
  15. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006; 12(30): 4819-4831. Go to original source... Go to PubMed...
  16. Chen CH, Lin CL, Kao CH. Association between Inflammatory Bowel Disease and Cholelithiasis: A Nationwide Population‑Based Cohort Study. Int J Environ Res Public Health. 2018 Mar 14; 15(3): 513. Go to original source... Go to PubMed...
  17. Duboc H, Rajca S, Rainteau D et al. Connecting dysbiosis, bile‑acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013; 62: 531-539. Go to original source... Go to PubMed...
  18. Fousekis FS, Theopistos VI, Katsanos KH et al. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review. Gastroenterology Res. 2018; 11(2): 83-94. Go to original source... Go to PubMed...
  19. Sturdik I, Krajcovicova A, Jalali Y et al. Pathophysiology and Risk Factors for Cholelithiasis in Patients with Crohn's Disease, Physiol. 68 (2): S173-S1821. Go to original source... Go to PubMed...
  20. Bessissow T, Le NH, Rollet K, et al. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease. Inflamm Bowel, DiS. 2016; 22 (8): 1937-1944. Go to original source... Go to PubMed...
  21. Obici L, Merlini G. Amyloidosis in autoinflammatory syndromes. Autoimmun Rev., 2012; 12(1): 14-17. Go to original source... Go to PubMed...
  22. Sharma P, Aguilar R, Siddiqui OA et al. Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis. Ann Gastroenterol. 2017; 30(5): 504-511. Go to original source... Go to PubMed...
  23. Sattianayagam PT, Gillmore JD, Pinney JH et al. Inflammatory bowel disease and systemic AA amyloidosis. Dig Dis Sci 2013; 58(6): 1689-1697. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.